Intravenous iron sucrose: Establishing a safe dose
Authors:
- Jatinder HarchowalJHJatinder Harchowal
- Iain C. MacdougallIMIain C. Macdougall
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 38 (5) , 988-991
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Intravenous administration of iron in epoetin‐treated haemodialysis patients—which drugs, which regimen?Nephrology Dialysis Transplantation, 2000
- Strategies for iron supplementation: Oral versus intravenousKidney International, 1999
- Iron supplementation in haemodialysis - practical clinical guidelinesNephrology Dialysis Transplantation, 1998
- The safety of intravenous iron dextran in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- Safety of intravenous injection of iron saccharate in haemodialysis patientsNephrology Dialysis Transplantation, 1996
- 'Oversaturation' of transferrin after intravenous ferric gluconate (FerrlecitR) in haemodialysis patientsNephrology Dialysis Transplantation, 1996
- Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysisAmerican Journal of Kidney Diseases, 1996
- Intravenous Ferric Saccharate as an Iron Supplement in Dialysis PatientsNephron, 1996
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987